Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEMOX vs CP as First-Line Therapy in Advanced NSCLC
NCT00087802Phase 3Completed
- Sponsor
- Sanofi
- Start
- Mar 2004
- Primary completion
- May 2007
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin in non-small cell lung cancer (NSCLC), sponsored by Sanofi. Started Mar 2004; status: completed.
02
Drugs
oxaliplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00087802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087802.